Cumberland Pharmaceuticals (CPIX) Price to Earnings (2010 - 2026)

Cumberland Pharmaceuticals has disclosed Price to Earnings across 17 years of filings, most recently posting 22.71 for Q2 2026.

• In Q2 2026, Price to Earnings rose 66.68% year-over-year to 22.71; the TTM figure through Jun 2026 stood at 9.01 (up 47.42% YoY), while the FY2025 annual figure was 20.88, down 306.8% from the prior year.
• Price to Earnings came in at 22.71 for Q2 2026 at Cumberland Pharmaceuticals, down from 15.5 in the prior quarter.
• In the past five years, Price to Earnings ranged from a high of 163.32 in Q1 2023 to a low of 82.21 in Q3 2022.
• Average Price to Earnings over 5 years is 9.53, with a median of 18.47 recorded in 2024.
• Year-over-year, Price to Earnings surged 651.39% in 2023 and tumbled 333.52% in 2024.
• Over 5 years, Price to Earnings stood at 13.14 in 2022, then soared by 69.48% to 4.01 in 2023, then plunged by 333.52% to 17.39 in 2024, then slumped by 141.85% to 42.06 in 2025, then jumped by 45.99% to 22.71 in 2026.
• Per Business Quant data, the three most recent Price to Earnings figures were 22.71 in Q2 2026, 15.5 in Q1 2026, and 42.06 in Q4 2025.